This $15M payment marks the second milestone achieved in the collaboration with Merck. Under the agreement, Neuphoria is eligible to receive up to $450M in additional milestone payments for certain ...
All Slate podcasts without any ads, including the Dear Prudence podcast.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback